Nasdaq · CIK 0001057379
HCKT HACKETT GROUP, INC.
Insider trading from SEC Form 4. Last filing Feb 23, 2026.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Signals
Open-market buys and sells at HACKETT GROUP, INC., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 53 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Robert A Rivero director | DDisposition to issuer Common Stock | -2,677 | $15.22 | $41k | 8,274 | Feb 23, 2026 |
| Feb 19, 2026 | Richard N Hamlin director | DDisposition to issuer Common Stock | -2,677 | $15.22 | $41k | 37,058 | Feb 23, 2026 |
| Feb 19, 2026 | John R Harris director | DDisposition to issuer Common Stock | -2,000 | $15.22 | $30k | 11,105 | Feb 23, 2026 |
| Feb 12, 2026 | Robert A Rivero director | AGrant or award Common Stock | +5,007 | $0.00 | $0 | 8,448 | Feb 17, 2026 |
| Feb 12, 2026 | Roberto A Ramirez Chief Financial Officer | AGrant or award Common Stock | +8,345 | $0.00 | $0 | 146,068 | Feb 17, 2026 |
| Feb 12, 2026 | Richard N Hamlin director | AGrant or award Common Stock | +5,007 | $0.00 | $0 | 37,232 | Feb 17, 2026 |
| Feb 12, 2026 | John R Harris director | AGrant or award Common Stock | +5,007 | $0.00 | $0 | 10,602 | Feb 17, 2026 |
| Feb 12, 2026 | Alan T G Wix director | AGrant or award Common Stock | +5,007 | $0.00 | $0 | 15,007 | Feb 17, 2026 |
| Feb 12, 2026 | Ted A Fernandez Chairman and CEO | AGrant or award Common Stock | +23,275 | $0.00 | $0 | 1,873,740 | Feb 17, 2026 |
| Feb 12, 2026 | David N Dungan Vice Chairman and COO | AGrant or award Common Stock | +12,219 | $0.00 | $0 | 819,877 | Feb 17, 2026 |
| Feb 12, 2026 | Maria de los Angeles Bofill director | AGrant or award Common Stock | +5,007 | $0.00 | $0 | 11,525 | Feb 17, 2026 |
| Feb 12, 2026 | Maria de los Angeles Bofill director | AGrant or award Common Stock | +2,503 | $0.00 | $0 | 14,028 | Feb 17, 2026 |
| Feb 12, 2026 | Alan T G Wix director | AGrant or award Common Stock | +2,503 | $0.00 | $0 | 17,510 | Feb 17, 2026 |
| Feb 12, 2026 | Robert A Rivero director | AGrant or award Common Stock | +2,503 | $0.00 | $0 | 10,951 | Feb 17, 2026 |
| Feb 12, 2026 | John R Harris director | AGrant or award Common Stock | +2,503 | $0.00 | $0 | 13,105 | Feb 17, 2026 |
| Feb 13, 2026 | Roberto A Ramirez Chief Financial Officer | FTax withholding Common Stock | -3,257 | $0.00 | $0 | 142,811 | Feb 17, 2026 |
| Feb 12, 2026 | Richard N Hamlin director | AGrant or award Common Stock | +2,503 | $0.00 | $0 | 39,735 | Feb 17, 2026 |
| Feb 13, 2026 | Ted A Fernandez Chairman and CEO | FTax withholding Common Stock | -30,169 | $0.00 | $0 | 1,843,571 | Feb 17, 2026 |
| Feb 13, 2026 | David N Dungan Vice Chairman and COO | FTax withholding Common Stock | -11,971 | $0.00 | $0 | 807,906 | Feb 17, 2026 |
| Sep 16, 2025 | David N Dungan Vice Chairman and COO | MOption exercise Common Stock | +137,705 | $0.00 | $0 | 869,267 | Nov 17, 2025 |
| Sep 16, 2025 | David N Dungan Vice Chairman and COO | FTax withholding Common Stock | -61,609 | $0.00 | $0 | 807,658 | Nov 17, 2025 |
| Sep 16, 2025 | David N Dungan Vice Chairman and COO | MOption exercise Performance Restricted Stock Unitsderivative | -137,705 | $0.00 | $0 | 275,410 | Nov 17, 2025 |
| Sep 16, 2025 | Ted A Fernandez Chairman and CEO | MOption exercise Common Stock | +262,295 | $0.00 | $0 | 1,953,678 | Oct 8, 2025 |
| Sep 16, 2025 | Roberto A Ramirez Chief Financial Officer | MOption exercise Common Stock | +24,000 | $0.00 | $0 | 147,167 | Oct 8, 2025 |
| Sep 16, 2025 | Roberto A Ramirez Chief Financial Officer | FTax withholding Common Stock | -9,444 | $0.00 | $0 | 137,723 | Oct 8, 2025 |
| Sep 16, 2025 | Ted A Fernandez Chairman and CEO | FTax withholding Common Stock | -103,213 | $0.00 | $0 | 1,850,465 | Oct 8, 2025 |
| Sep 16, 2025 | Roberto A Ramirez Chief Financial Officer | MOption exercise Performance Restricted Stock Unitsderivative | -24,000 | $0.00 | $0 | 48,000 | Oct 8, 2025 |
| Sep 16, 2025 | Ted A Fernandez Chairman and CEO | MOption exercise Performance Restricted Stock Unitsderivative | -262,295 | $0.00 | $0 | 524,590 | Oct 8, 2025 |
| Feb 20, 2025 | Maria de los Angeles Bofill director | DDisposition to issuer Common Stock | -3,282 | $30.78 | $101k | 6,518 | Feb 24, 2025 |
| Feb 20, 2025 | John R Harris director | DDisposition to issuer Common Stock | -923 | $30.78 | $28k | 5,595 | Feb 24, 2025 |
| Feb 20, 2025 | Alan T G Wix director | DDisposition to issuer Common Stock | -3,077 | $30.78 | $95k | 10,000 | Feb 24, 2025 |
| Feb 20, 2025 | Robert A Rivero director | DDisposition to issuer Common Stock | -3,077 | $30.78 | $95k | 3,441 | Feb 24, 2025 |
| Feb 14, 2025 | Roberto A Ramirez Chief Financial Officer | FTax withholding Common Stock | -5,233 | $31.94 | $167k | 163,167 | Feb 24, 2025 |
| Feb 14, 2025 | David N Dungan Vice Chairman and COO | FTax withholding Common Stock | -23,453 | $31.94 | $749k | 731,562 | Feb 24, 2025 |
| Feb 14, 2025 | Ted A Fernandez Chairman and CEO | FTax withholding Common Stock | -42,751 | $31.94 | $1.4M | 1,691,383 | Feb 24, 2025 |
| Feb 20, 2025 | Roberto A Ramirez Chief Financial Officer | DDisposition to issuer Common Stock | -40,000 | $30.78 | $1.2M | 123,167 | Feb 24, 2025 |
| Feb 14, 2025 | Richard N Hamlin director | AGrant or award Common Stock | +1,147 | $0.00 | $0 | 29,931 | Feb 19, 2025 |
| Feb 14, 2025 | Alan T G Wix director | AGrant or award Common Stock | +1,147 | $0.00 | $0 | 10,783 | Feb 19, 2025 |
| Feb 14, 2025 | Robert A Rivero director | AGrant or award Common Stock | +1,147 | $0.00 | $0 | 4,224 | Feb 19, 2025 |
| Feb 14, 2025 | Roberto A Ramirez Chief Financial Officer | AGrant or award Common Stock | +3,360 | $0.00 | $0 | 164,576 | Feb 19, 2025 |
| Feb 14, 2025 | John R Harris director | AGrant or award Common Stock | +1,147 | $0.00 | $0 | 4,224 | Feb 19, 2025 |
| Feb 14, 2025 | Ted A Fernandez Chairman and CEO | AGrant or award Common Stock | +60,998 | $0.00 | $0 | 1,734,134 | Feb 19, 2025 |
| Feb 14, 2025 | David N Dungan Vice Chairman and COO | AGrant or award Common Stock | +32,024 | $0.00 | $0 | 755,015 | Feb 19, 2025 |
| Feb 14, 2025 | Maria de los Angeles Bofill director | AGrant or award Common Stock | +1,147 | $0.00 | $0 | 7,506 | Feb 19, 2025 |
| Feb 14, 2025 | Richard N Hamlin director | AGrant or award Common Stock | +2,294 | $0.00 | $0 | 32,225 | Feb 19, 2025 |
| Feb 14, 2025 | John R Harris director | AGrant or award Common Stock | +2,294 | $0.00 | $0 | 6,518 | Feb 19, 2025 |
| Feb 14, 2025 | Roberto A Ramirez Chief Financial Officer | AGrant or award Common Stock | +3,824 | $0.00 | $0 | 168,400 | Feb 19, 2025 |
| Feb 14, 2025 | Robert A Rivero director | AGrant or award Common Stock | +2,294 | $0.00 | $0 | 6,518 | Feb 19, 2025 |
| Feb 14, 2025 | Maria de los Angeles Bofill director | AGrant or award Common Stock | +2,294 | $0.00 | $0 | 9,800 | Feb 19, 2025 |
| Feb 14, 2025 | Alan T G Wix director | AGrant or award Common Stock | +2,294 | $0.00 | $0 | 13,077 | Feb 19, 2025 |
| Sep 16, 2024 | David N Dungan Vice Chairman and COO | AGrant or award Performance Restricted Stock Unitsderivative | +413,115 | $0.00 | $0 | 413,115 | Feb 19, 2025 |
| Sep 16, 2024 | Roberto A Ramirez Chief Financial Officer | AGrant or award Performance Restricted Stock Unitsderivative | +72,000 | $0.00 | $0 | 72,000 | Feb 19, 2025 |
| Sep 16, 2024 | Ted A Fernandez Chairman and CEO | AGrant or award Performance Restricted Stock Unitsderivative | +786,885 | $0.00 | $0 | 786,885 | Feb 19, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Maria de los Angeles Bofilldirector
- David N DunganVice Chairman and COO
- Ted A FernandezChairman and CEO
- Richard N Hamlindirector
- John R Harrisdirector
- Roberto A RamirezChief Financial Officer
- Robert A Riverodirector
- Alan T G Wixdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.